Annexin V and terminal differentiation of growth plate chondrocytes.
Terminal differentiation and mineralization are the final events in endochondral bone formation and allow the replacement of cartilage by bone. Retinoic acid (RA) stimulates these events, including upregulation of expression and activity of alkaline phosphatase (APase), expression of annexins II, V, and VI proteins, which bind to membranes and form Ca(2+) channels, expression of osteocalcin and runx2, another mineralization-related protein and terminal differentiation-related transcription factor, and ultimately mineralization. Chelating cytosolic Ca(2+) with BAPTA-AM, interfering with annexin Ca(2+) channel activities using K-201, a specific annexin Ca(2+) channel blocker, or suppression of annexin V expression using siRNA inhibited these events. Overexpression of annexin V in embryonic chicken growth plate chondrocytes resulted in an increase of cytoplasmic Ca(2+) concentration, [Ca(2+)](i) similar to [Ca(2+)](i) increase in RA-treated cultures. Overexpression of annexin V also resulted in upregulation of annexin II, annexin VI, osteocalcin, and runx2 gene expression, expression and activity of APase, and ultimately stimulation of mineralization. K-201 inhibited upregulation of osteocalcin and runx2 gene expression, APase expression and activity, and mineralization in annexin V-overexpressing growth plate chondrocytes. These findings indicate that annexins II, V, and VI alter Ca(2+) homeostasis in growth plate chondrocytes thereby regulating terminal differentiation and mineralization events. Overexpression of annexin V is sufficient to stimulate these terminal differentiation events in growth plate chondrocytes, whereas suppression of annexin V expression inhibits these events.
Wang
Wei
W
Department of Orthopaedics, Musculoskeletal Research Laboratories, University of Maryland School of Medicine, 22 S. Greene St. S11B, Baltimore, MD 21201, USA.
Xu
Jinping
J
Kirsch
Thorsten
T
D000469:Alkaline Phosphatase / Q000378:metabolism; D000818:Animals; D017304:Annexin A5 / Q000235:genetics* / Q000502:physiology; D002118:Calcium / Q000378:metabolism; D002454:Cell Differentiation / Q000187:drug effects / Q000502:physiology*; D002642:Chick Embryo; D019902:Chondrocytes / Q000166:cytology / Q000187:drug effects / Q000502:physiology; D017931:DNA Primers; D018507:Gene Expression Regulation, Developmental; D006132:Growth Plate / Q000166:cytology* / Q000187:drug effects / Q000196:embryology / Q000502:physiology; D016133:Polymerase Chain Reaction; D014212:Tretinoin / Q000494:pharmacology
D017304:Annexin A5; D017931:DNA Primers; D014212:Tretinoin; D000469:Alkaline Phosphatase; D002118:Calcium